Skip to main content
Home
Sign in | Register
  • Conditions of sale
  • FAQ
  • Resource center
  • Product documentation
  • Partner portal
  • Sign in | register
United States of America
  • Home
  • News & events
  • LUMIPULSE® G1200 now available in the United States

LUMIPULSE® G1200 now available in the United States

Product news
May 11, 2015

Malvern PA, USA - May 11, 2015 - Fujirebio US, Inc. now offers the LUMIPULSE G1200, a robust mid-sized fully automated immunoassay instrument.  The LUMIPULSE G1200 is FDA cleared and offers clinical laboratories a unique and user friendly system with multiple features to simplify workflow.

Related events

Apr 5, 2019 - Apr 10, 2019

AAN American Academy of Neurology

Pennsylvania Convention Center - Philadelphia, PA,
United States of America

More info and meet us there

Jun 3, 2019 - Jun 6, 2019

2019 APHL Annual Meeting

St. Louis Union Station Hotel - St. Louis, MO,
United States of America

More info and meet us there

Related articles

Jun 12, 2018

Fujirebio Diagnostics Announces FDA Clearance of Lumipulse G B•R•A•H•M•S PCT Assay

Fujirebio Diagnostics, Inc., a consolidated subsidiary of Miraca Holdings Inc., has received U.S. Food and Drug Administration (FDA) clearance of the company’s Lumipulse® G B•R•A•H•M•S PCT Assay for testing on its LUMIPULSE® G1200 immunoassay platform.​​​​​​​

Read more

Veuillez confirmer que vous êtes un professionnel de la santé

Le contenu de ce site web est en partie réservé aux professionnels de santé qui sont directement impliqués dans la fourniture de services de soins de santé aux patients. Si vous êtes un professionnel de santé et que vous disposez de tous les droits d'accès, veuillez confirmer en cliquant sur le bouton 'oui'.

Choose your country or region

Once you have made this selection we will show you only the content that is relevant for your country. You can change this setting any time by clicking on the flag in the top toolbar of our website and choosing another country.
The content of this website is in part restricted to healthcare professionals who are directly involved in the provision of healthcare services to patients. If you are a health professional and you have full access rights, please check this box and confirm below.
Home
  • Home
  • About Fujirebio
  • Products & solutions
  • Neuro
  • HPV
  • CDMO (OEM)
  • Quality
  • Insights
  • News & events
  • Careers
  • Contact
  • Whistleblower Policy
  • Conditions of sale
  • FAQ
  • Resource center
  • Product documentation
  • Partner portal
  • Sign in | register

Follow us on:

FUJIREBIO is an H.U. Group company.

  • © Fujirebio
  • Website Terms and Conditions
  • Privacy Policy
  • Cookie Policy
  • Trasparenza
site by D'M&S
  • Home
  • About Fujirebio
    • Message from the CEO
    • Global leadership
    • Fujirebio at a glance
    • History
    • Global Office Locations
    • Sustainability and social responsability
  • Products & solutions
  • Neuro
    • Alzheimer's disease testing solutions
    • The Fujirebio Neuro Center of Excellence
    • NExT - the Neuro Expert Toolbox
  • HPV
  • CDMO (OEM)
    • Antibody Identification and Characterization
    • Antibody Supply
    • Contract Manufacturing
    • Product Development
    • Clinical Services
    • Regulatory Services
  • Quality
  • Insights
  • News & events
  • Careers
  • Contact
  • Whistleblower Policy
  • Conditions of sale
  • FAQ
  • Resource center
  • Product documentation
  • Partner portal
  • Sign in | register
Sign in | Register